Web Results

law.justia.com/cases/federal/district-courts/illinois/ilndce/1:2017cv06730/344210/60

Apr 13, 2018 ... Al Haj et al v. Pfizer Inc, No. 1:2017cv06730 - Document 60 (N.D. Ill. 2018) case opinion from the Northern District of Illinois US Federal District ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19-0.html

Jan 19, 2018 ... Rodney Guilbeau v. Pfizer Inc., No. 17-2056 (7th Cir. 2018) case opinion from the US Court of Appeals for the Seventh Circuit.

www.law360.com/cases/53c59fb78074bd3ed1000001

Parties, docket activity and news coverage of federal case American Sales Company, LLC v. Pfizer, Inc. et al, case number 2:14-cv-00361, from Virginia Eastern ...

www.law360.com/articles/912973/pfizer-can-t-shake-off-label-marketing-fca-suit

Apr 12, 2017 ... The case is United States of America et al. ex rel. Catherine A. Brown et al. c. Pfizer Inc., case number 2:05-cv-06795 in the U.S. District Court ...

caselaw.findlaw.com/ca-court-of-appeal/1211311.html

Court of Appeal, First District, Division 2, California. James CLAYWORTH, et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Defendants and Respondents.

bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0280-0

Ilenia Migliaccio,; Luca Malorni,; Christopher D Hart,; Cristina Guarducci and; Angelo Di LeoEmail author ... Migliaccio et al.; licensee BioMed Central. 2015.

www.sciencedirect.com/science/article/pii/S0149291813009430

Of these, 5.8% switched, 51.3% permanently discontinued all anticholinergic agents, and .... Detrol, Detrol LA and Toviaz (Pfizer Inc., New York, New York). ‡ .... switches are almost one third the rate observed by D'Souza et al (5.8% vs 13 %). ... Ms. Migliaccio-Walle led the manuscript preparation, provided oversight and ...

mcr.aacrjournals.org/content/molcanres/14/5/470.full.pdf

Mar 10, 2016 ... postmenopausal patients with all stages of ER ю breast cancer (1). ...... Luca Malorni, Mario Giuliano, Ilenia Migliaccio, et al. Resistance.

clincancerres.aacrjournals.org/content/22/23/5755

However, not all patients have a durable response with single endocrine agents, and ... The OncotypeDx recurrence score (Genomic Health Inc) is clinically ..... L. Malorni is a consultant/advisory board member for Pfizer and provided expert ..... Rossi S,; Basso M,; Strippoli A,; Dadduzio V,; Cerchiaro E,; Barile R,; et al.